Module 4 of 7: Managing Patients on Opioids for Acute Pain
April 03, 2020
Michael A. Kelly, MD
Chairman, Department of Orthopedics and Sports Medicine
Founding Chairman of Orthopedic Surgery
Professor of Orthopedic Surgery
Hackensack Meridian School of Medicine at Seton Hall, Nutley, New Jersey
Co-Director, Musculoskeletal Care of Transformation Service
Hackensack Meridian Health, Hackensack, New Jersey
Clinical Professor of Orthopedic Surgery
Rutgers University Medical School, Newark, New Jersey
Dr. Kelly has been the Chairman of the Department of Orthopaedic Surgery and Sports Medicine since 2005, and is currently a Professor of Orthopaedic Surgery at Rutgers New Jersey Medical School. He was a founding member of the Insall Scott Kelly Institute since 1991 where he remains a director. He is past president of the U.S. Knee Society and is the recent Chair of the Adult Reconstruction Knee Committee at the American Academy of Orthopaedic Surgeons.Aakash Shah, MD, MBA
Attending Physician, Department of Emergency Medicine, Hackensack Meridian Health
Hackensack University Medical Center
Medical Director of Substance Use Disorder Program Development
Medical Director of Hospital-Based Violence Intervention Program
Hackensack Meridian Health, Hackensack, New Jersey
Department of Psychiatry and Behavioral Health
Jersey Shore University Medical Center, Neptune, New Jersey
Dr. Shah is a practicing emergency room doctor specializing in addiction medicine at Hackensack Meridian Health (HMH). At HMH, he also serves as the Medical Director for Substance Use Disorder Program Development and the Medical Director for the Hospital-Based Violence Intervention Program.He also serves as the Medical Director of New Jersey Reentry Corporation (NJRC) where he provides guidance on initiatives to better meet the healthcare needs of the justice-involved population. His work at NJRC has resulted in several statewide policy and programmatic reforms (including the elimination of prior authorization requirements for medication-assisted treatment and universal screening and treatment of hepatitis in prisons) as well as received the bipartisan endorsement of five former New Jersey Governors, several local editorial boards, and major healthcare systems.
Prior to his work with NJRC, Aakash was the Founder and Executive Director of Be Jersey Strong, which trained students to serve as community health workers. During the third open enrollment period, Be Jersey Strong recruited over 500 students – two-thirds of whom spoke a second language with over 50 languages represented – from over 20 campuses to help inform New Jerseyans of their options for coverage. The initiative represented one of the largest and most diverse efforts to connect the insured to coverage in the nation and was honored by then President Barack Obama at the White House for its impact.
Aakash has also staffed the health policy transition committee for Governor Phil Murphy of New Jersey, served on the health policy councils of three gubernatorial campaigns, and advised the New Jersey Senate Majority Leader and members of the United States House of Representatives. In these roles, his portfolio has included initiatives to combat the opioid crisis, determine the health impact of burn pit exposure during military service, expand paid family leave, secure financing for women’s health, establish Medicaid Accountable Care Organizations (ACOs), and implement the Affordable Care Act (ACA).
He has conducted original research in these areas at Rutgers University, Boston Children’s Hospital, Brigham and Women’s Hospital, Massachusetts General Hospital, Harvard Medical School, and Oxford University. He is the author of several peer-reviewed publications, op-eds, and policy reports as well as the anthology The Soul of a Patient. He has secured over $2 million dollars in federal and state grant funding to date.
He obtained his MD from Harvard Medical School. He completed his MBA and MSc in Comparative Social Policy from Oxford University as a Rhodes Scholar. He received his BA and BS from Ursinus College. He currently serves on the board of trustees for Integrity House and Ursinus College, and previously served on the executive board of New Leaders Council – New Jersey.
Michael D. Stillman, MD
Associate Professor in Medicine and Attending Physician, Department of Medicine
Associate Professor in Rehabilitation Medicine and Attending Physician, Department of Rehabilitation Medicine
Sidney Kimmel Medical College, Thomas Jefferson University
Philadelphia, Pennsylvania
Michael Stillman, MD is an Associate Professor of Internal Medicine at Sidney Kimmel Medical College of Thomas Jefferson University.
A general internist with expertise in caring for people with chronic disabilities, Dr. Stillman has interest in provision of equitable primary care for people with mobility disabilities and in evaluating and treating a number of secondary conditions of chronic disability, including myofascial and neuropathic pain.
Dr. Stillman has delivered academic lectures around the country and has over 40 peer-reviewed publications.
Ramon Solhkhah, MD, MBA
Founding Chair, Department of Psychiatry & Behavioral Health
Professor of Psychiatry & Behavioral Health and Pediatrics
Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey
Chair, Department of Psychiatry; Jersey Shore University Medical Center, Neptune, New Jersey
Corporate Medical Director, (Legacy) Meridian Behavioral Health Services
Clinical Associate Professor and Vice-Chairman, Department of Psychiatry
Rutgers - Robert Wood Johnson Medical School, New Brunswisk, New Jersey
Dr. Solhkhah is the Chairman of the Department of Psychiatry at JSUMC (JSUMC; Neptune, NJ) and Corporate Medical Director of Meridian Behavioral Health Services for the past seven years. Prior to his arrival at JSUMC, Dr. Solhkhah was the Vice Chairman for Education of the Department of Psychiatry and Director of the Child & Adolescent Outpatient Service (CAOS) at Maimonides Medical Center. Dr. Solhkhah has also held posts as the Associate Chairman of the Department of Psychiatry, Director of the Child and Family Institute and the Chief of the Division of Child & Adolescent Psychiatry in the Department of Psychiatry at St. Luke’s-Roosevelt Hospital Center, a University Hospital of Columbia University College of Physicians and Surgeons. Previously he was Coordinator of Substance Abuse Services at the New York University Child Study Center.Dr. Solhkhah, a member of the American Psychiatric Association, the American Society of Addiction Medicine, and the American Academy of Child and Adolescent Psychiatry, is an active clinical researcher who has taught, lectured, and written extensively in child psychiatry and in the area of adolescent substance abuse.
Tyler S. Oesterle, MD, MPH, Expert Independent Reviewer
Medical Director, Fountain Centers Chemical Dependency Treatment Program
Department of Psychiatry and Psychology, Mayo Health System
Assistant Professor of Psychiatry, Mayo Clinic College of Medicine and Science
Rochester, Minnesota
Tyler S. Oesterle, M.D., M.P.H., is medical director of the Mayo Clinic Intensive Addiction Program (IAP) and medical director of Fountain Centers, chemical dependency treatment programs that are part of the Department of Psychiatry and Psychology, Mayo Clinic. Dr. Oesterle joined the staff of Mayo Clinic in 2014 and holds the academic rank of assistant professor of psychiatry, Mayo Clinic College of Medicine and Science.
Dr. Oesterle earned his B.A. at Brigham Young University in Provo, Utah, and his M.D. at the University of Minnesota Medical School, Twin Cities. He subsequently earned his M.P.H. at the University of Minnesota School of Public Health. Dr. Oesterle continued his training through a residency in child and adolescent psychiatry and a fellowship in addiction medicine at Mayo Clinic School of Graduate Medical Education.
Dr. Oesterle’s clinical interest is in treatment for complex addition, as well as rural mental health, with a focus on child and adolescent psychiatry and addiction psychiatry. Dr. Oesterle’s research focuses on genetics of addiction, rural chemical dependency treatment, evidence-based treatment for opioid use disorder, and child outcomes associated with parental opioid use. He has given many presentations on his work and has authored journal articles, abstracts and other written publications.
Dr. Oesterle’s professional memberships include the American Psychiatric Association, American Academy of Addiction Psychiatry, and American Academy of Child and adolescrnt Psychiatry.
TARGET AUDIENCE
The primary audience for this initiative will be all providers eligible to prescribe opioid analgesics. A secondary audience includes non-prescribers involved in the care of patients receiving opioid analgesic therapy, nonpharmacologic therapies, and non-opioid medication therapies for the management of pain. These include providers directly employed by Jefferson Health and Hackensack Meridian Health, as well as providers within affiliated practices throughout the service areas served by these organizations. Specifically, this will include allopathic and osteopathic physicians, dentists and oral surgeons, residents and fellows, physician assistants, nurse practitioners, pharmacists, floor nurses, rehabilitation service providers (i.e., occupational and physical therapists), case managers, and social workers and others involved in direct patient care as prescribers and non-prescribers.
LAUNCH DATE/EXPIRATION DATE
This activity was initially launched on April 3, 2020 and will expire on April 2, 2022 (for ACCME and ADA credit). Please see valid activity participation dates specific to other continuing education credit approvals below.
ACCREDITATION STATEMENTS
Accreditation Council for Continuing Medical Education (ACCME) Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedicusCME, Hackensack Meridian Health and Thomas Jefferson University College of Population Health. MedicusCME is accredited by the ACCME to provide continuing medical education for physicians.
ACCME Designation Statement
MedicusCME designates this enduring material for a maximum of 3.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Dental Association (ADA) Continuing Education Recognition Program
Jersey Shore University Medical Center is an ADA CERP Recognized Provider. Approval from 11-1-2018 to 12-31-2022 . ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Jersey Shore University Medical Center designates this activity for 3.5 continuing education credits. ADA CERP Recognized Provider credits are recognized by AGD PACE for Fellowship and Mastership credit.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center (ANCC) and the Ohio Nurses Association through the joint providership of MedicusCME, Hackensack Meridian Health and Thomas Jefferson University College of Population Health.
This nursing continuing professional development activity was approved by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)
Activity ID: 2020-0000000317 has received ONA approval for 3.50 contact hours
Approval valid from 06/23/2020
Approval valid through 06/23/2022
New Jersey State Board of Physical Therapy Examiners
This physical therapy continuing professional development activity was approved by the New Jersey State Board of Physical Therapy Examiners for 3.50 credits.
Approval Number: 2005-52
The course approval expires on January 31, 2022.
HOW TO CLAIM CREDIT
In order to receive CE credit and ANCC contact hours, participants must do the following:
- Read the learning objectives and faculty disclosures.
- Participate in the activity, review course content and learning strategies, resources and support materials provided
- All seven (7) Self Study Modules must be completed to receive credit.
- Complete the post-test and activity evaluation.
- CE credit for additional disciplines is under consideration. All participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE FORMAT/MEDIUM: Internet Activity (Enduring Material)
ESTIMATED TIME TO COMPLETE ALL SEVEN (7) MODULES: 3.5 hours
ACKNOWLEDGEMENTS
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see
https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf
for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
MedicusCME represents that the Program shall conform to and comply with the AMA Ethical Opinions 8.061 (Gifts to Physicians from Industry) and 9.011 (Ethical Issues in CME) and the pharmaceutical Research and Manufacturers Association Code on Interactions with Healthcare Professionals.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
INSTITUTION LEADERS
David S. Kountz, M.D., MBA, FACP
Vice President, Academic Affairs, Jersey Shore University Medical Center
Co-Chief Academic Officer, Hackensack Meridian Health, Neptune, New Jersey
Associate Dean, Diversity and Equity, Hackensack Meridian School of Medicine at Seton Hall
University, Nutley, New Jersey
Willie H. Oglesby, PhD, MBA, MSPH, FACHE
Interim Dean, Jefferson College of Population Health
Associate Professor, Jefferson College of Population Health
Thomas Jefferson University, Philadelphia, Pennsylvania
FACULTY CONTENT TEAM
Michael A. Kelly, MD
Chairman, Department of Orthopedics and Sports Medicine
Founding Chairman of Orthopedic Surgery
Professor of Orthopedic Surgery
Hackensack Meridian School of Medicine at Seton Hall, Nutley, New Jersey
Co-Director, Musculoskeletal Care of Transformation Service
Hackensack Meridian Health, Hackensack, New Jersey
Clinical Professor of Orthopedic Surgery
Rutgers University Medical School, Newark, New Jersey
Aakash Shah, MD, MBA
Attending Physician, Department of Emergency Medicine, Hackensack Meridian Health
Hackensack University Medical Center
Medical Director of Substance Use Disorder Program Development
Medical Director of Hospital-Based Violence Intervention Program
Hackensack Meridian Health, Hackensack, New Jersey
Department of Psychiatry and Behavioral Health
Jersey Shore University Medical Center, Neptune, New Jersey
Ramon Solhkhah, MD, MBA
Founding Chair, Department of Psychiatry & Behavioral Health
Professor of Psychiatry & Behavioral Health and Pediatrics
Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey
Chair, Department of Psychiatry; Jersey Shore University Medical Center, Neptune, New Jersey
Corporate Medical Director, (Legacy) Meridian Behavioral Health Services
Clinical Associate Professor and Vice-Chairman, Department of Psychiatry
Rutgers - Robert Wood Johnson Medical School, New Brunswisk, New Jersey
Michael D. Stillman, MD
Associate Professor in Medicine and Attending Physician, Department of Medicine
Associate Professor in Rehabilitation Medicine and Attending Physician, Department of Rehabilitation Medicine
Sidney Kimmel Medical College, Thomas Jefferson University
Philadelphia, Pennsylvania
EXPERT INDEPENDENT REVIEWER
Tyler S. Oesterle, MD, MPH
Medical Director, Fountain Centers Chemical Dependency Treatment Program
Department of Psychiatry and Psychology, Mayo Health System
Assistant Professor of Psychiatry, Mayo Clinic College of Medicine and Science
Rochester, Minnesota
PLANNERS
Paul J. Cordello, DMD
Director of Continuing Dental Education, Jersey Shore University Medical Center
Hackensack Meridian Health, Neptune, New Jersey
Steven Haimowitz, MD
President, RealCME
Carol Pashman, MS, RN
President, MedicusCME
MEDICAL WRITER
Joshua Schechtel, MD
MedicusCME’s POLICY ON CONFLICT OF INTEREST
It is the policy of MedicusCME to identify and resolve any potential conflicts of interest of anyyone who may be in a position to influence or control the content of an education activity, to assure balance, independence, objectivity and scientific rigor in all of its accredited activities. All faculty and planners are expected to disclose all financial relationships with a commercial interest within the past twelve months.
CONFLICT OF INTEREST DISCLOSURES
Dr. Michael Kelly acknowledges receipt of honoraria from Depuy Synthes for his role as faculty presenter.
All other members of the Faculty Content Team, authors and planners, and the Expert Content Reviewer of this accredited activity deny any personal or financial relationships with ACCME-defined commercial entities that may constitute any real or perceived conflict of interest.
